Peak Pharmaceuticals (OTCMKTS:PKPH) Shares Up 27.8% – Time to Buy?

Peak Pharmaceuticals, Inc. (OTCMKTS:PKPHGet Free Report) shot up 27.8% during trading on Monday . The stock traded as high as $1.3162 and last traded at $1.3162. 130 shares traded hands during trading, a decline of 99% from the average session volume of 9,053 shares. The stock had previously closed at $1.03.

Peak Pharmaceuticals Stock Performance

The firm’s 50 day simple moving average is $1.68 and its 200 day simple moving average is $1.75.

Peak Pharmaceuticals Company Profile

(Get Free Report)

Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.

Recommended Stories

Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.